CoChat
Sign Up
Cited by 325

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration

Schleh, Carsten, Semmler-Behnke, Manuela, Lipka, Jens, Wenk, Alexander, Hirn, Stephanie, Schäffler, Martin, Schmid, Günter, Simon, Ulrich, Kreyling, Wolfgang G.·2012·Nanotoxicology
DOI 10.3109/17435390.2011.552811PMC PMC3267526
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/17435390.2011.552811

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 NP content which reached the circulation after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. ***p < 0.001.
Figure 1 NP content which reached the circulation after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. ***p < 0.001.CC BY · PubMed Central
Figure 2 NP content which accumulated in secondary organs, the remainder, as well as the urine after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. *p < 0.05; ***p < 0.001; nd, not detected.
Figure 2 NP content which accumulated in secondary organs, the remainder, as well as the urine after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. *p < 0.05; ***p < 0.001; nd, not detected.CC BY · PubMed Central
Figure 3 NP content which reached the circulation after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. *p < 0.05 vs 1.4 nm; **p < 0.01 vs. 1.4 nm; ***p < 0.001 vs 1.4 nm.
Figure 3 NP content which reached the circulation after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. *p < 0.05 vs 1.4 nm; **p < 0.01 vs. 1.4 nm; ***p < 0.001 vs 1.4 nm.CC BY · PubMed Central
Figure 4 NP content which accumulated the blood (A), reticulo endothelial system (RES; liver plus spleen), (B), kidney (C), as well as urine (D) after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. *p < 0.05 vs 1.4 nm; **p < 0.01 vs. 1.4 nm; ***p < 0.001
Figure 4 NP content which accumulated the blood (A), reticulo endothelial system (RES; liver plus spleen), (B), kidney (C), as well as urine (D) after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. *p < 0.05 vs 1.4 nm; **p < 0.01 vs. 1.4 nm; ***p < 0.001CC BY · PubMed Central
Figure 5 NP content which accumulated the heart (A), and brain (B) after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. #p < 0.05 vs. 18 nm; ##p < 0.01 vs. 18 nm; nd, not detected.
Figure 5 NP content which accumulated the heart (A), and brain (B) after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. #p < 0.05 vs. 18 nm; ##p < 0.01 vs. 18 nm; nd, not detected.CC BY · PubMed Central
Figure 6 NP content which accumulated in the remaining carcass after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. *p < 0.05 vs. 1.4 nm; **p < 0.01 vs. 1.4 nm; ***p < 0.001 vs. 1.4 nm.
Figure 6 NP content which accumulated in the remaining carcass after intra-oesophageal application in % of administered particle-amount. Given is the mean ± standard error of the mean of four animals. *p < 0.05 vs. 1.4 nm; **p < 0.01 vs. 1.4 nm; ***p < 0.001 vs. 1.4 nm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 50

  1. 10.1016/j.addr.2009.03.009 · DOI · Paper page
  2. 10.1021/la0528450 · DOI
  3. 10.1021/ja050793v · DOI
  4. 10.1007/s11095-009-9965-4 · DOI
  5. 10.1016/j.biomaterials.2009.01.057 · DOI · Paper page
  6. 10.1016/j.toxlet.2009.04.017 · DOI
  7. 10.1002/smll.200400093 · DOI
  8. 10.1016/j.jconrel.2006.08.013 · DOI · Paper page
  9. 10.1016/j.ejps.2005.04.015 · DOI
  10. 10.1016/j.nano.2008.08.001 · DOI
  11. 10.1016/j.ijpharm.2006.10.043 · DOI
  12. 10.3109/10611869509015936 · DOI
  13. Florence AT. 2007. Pharmaceutical nanotechnology: More than size. Ten topics for research. Int J Pharm 339(1–2):1–2. · DOI
  14. 10.1016/S0168-3659(99)00237-0 · DOI
  15. 10.1016/S0074-7696(08)61346-7 · DOI
  16. 10.1289/ehp.8006 · DOI
  17. 10.1016/j.biomaterials.2010.01.065 · DOI · Paper page
  18. 10.3109/10611869409015904 · DOI
  19. 10.1002/jps.1143 · DOI
  20. Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schäffler M, Takenaka S, Möller W, Schmid G, Simon U, Kreyling WG. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm. 2010 Dec 31. [Epub ahead of print]
  21. 10.1023/A:1011981610840 · DOI
  22. Jani P, Halbert GW, Langridge J, Florence AT. 1989. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol 41(12):809–812. · DOI
  23. 10.3109/10611869609046266 · DOI
  24. 10.1021/la100810z · DOI
  25. 10.1021/nn9011187 · DOI
  26. 10.1073/pnas.0805135105 · DOI · Paper page
  27. 10.1021/la0484725 · DOI
  28. Nassimi M Schleh C Lauenstein HD Hussein R Hoymann HG Koch W Pohlmann G Krug N Sewald K Rittinghausen S Braun A Muller-Goymann C. 2010. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm 75(2):107–116. · DOI
  29. 10.1080/08958370903005769 · DOI
  30. Oeff K, Konig A. 1955. Das Blutvolumen einiger Rattenorgane und ihre Restblutmenge nach entbluten bzw. durchspülung - Bestimmung mit P-32-markierten Erythrocyten. Naunyn-Schmiedebergs Archiv Fur Experimentelle Pathologie Und Pharmakologi 226(1):98–102.
  31. 10.1002/smll.200900466 · DOI
  32. 10.1002/smll.200700378 · DOI
  33. 10.1242/dev.110.4.1001 · DOI
  34. 10.1016/j.jaut.2009.11.006 · DOI
  35. 10.1016/j.vaccine.2004.11.007 · DOI
  36. 10.1016/j.jconrel.2009.10.032 · DOI
  37. 10.1016/j.biomaterials.2007.10.026 · DOI
  38. Sass W, Dreyer HP, Seifert J. 1990. Rapid insorption of small particles in the gut. Am J Gastroenterol 85(3):255–260.
  39. 10.1039/b713631p · DOI
  40. 10.1159/000171250 · DOI
  41. Seifert J, Haraszti B, Sass W. 1996. The influence of age and particle number on absorption of polystyrene particles from the rat gut. J Anat 189(Pt 3):483–486.
  42. 10.1002/smll.200800922 · DOI
  43. 10.1002/smll.200800995 · DOI
  44. 10.1016/j.ijpharm.2007.06.049 · DOI
  45. 10.1016/j.colsurfb.2008.02.013 · DOI
  46. 10.1039/b712170a · DOI
  47. 10.1246/cl.1996.1033 · DOI
  48. 10.1016/j.ijpharm.2004.12.028 · DOI
  49. 10.1021/la0497200 · DOI
  50. 10.1021/ja910675v · DOI

Cited by

Sorted by citations

See all 325

Metadata

Authors
Schleh, C., Semmler-Behnke, M., Lipka, J., Wenk, A., Hirn, S., Schäffler, M., Schmid, G., Simon, U., & Kreyling, W. G.
Venue
Nanotoxicology
Publisher
Informa UK Limited
Published
2011-02-10
Volume
6
Issue
1
Pages
36-46
ISSN
  • 1743-5390
  • 1743-5404
DOI
10.3109/17435390.2011.552811
PMC
PMC3267526
Cited by
325
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. https://app.cochat.ai/papers/10.3109/17435390.2011.552811
The paper
Schleh, C., Semmler-Behnke, M., Lipka, J., Wenk, A., Hirn, S., Schäffler, M., Schmid, G., Simon, U., & Kreyling, W. G. (2012). Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology. https://doi.org/10.3109/17435390.2011.552811